ATRC

SEC source: 0001336063-26-000010 · wk-form4_1790283650.xml · nonDerivative · entry 1

Privitera Salvatore · CIK 0001336063 · Chief Technical Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 142,745

F1 · shares: These shares were sold pursuant to a 10b5-1 trading plan adopted on February 20, 2026

SEC source: 0001653877-26-000006 · wk-form4_1789422288.xml · nonDerivative · entry 1

GROVES REGINA E · CIK 0001653877 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 34,546

F1 · price: This transaction was executed in multiple trades at prices ranging from $54.09 to $54.38 per share. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

SEC source: 0001336063-26-000008 · wk-form4_1789046280.xml · nonDerivative · entry 1

Privitera Salvatore · CIK 0001336063 · Chief Technical Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 147,264

F1 · shares: These shares were sold pursuant to a 10b5-1 trading plan adopted on February, 20, 2026.

SEC source: 0001336063-26-000006 · wk-form4_1788521967.xml · nonDerivative · entry 1

Privitera Salvatore · CIK 0001336063 · Chief Technical Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 150,921

F1 · shares: These shares were sold pursuant to a 10b5-1 trading plan adopted on February 20, 2026.

SEC source: 0001861996-26-000006 · wk-form4_1787741408.xml · nonDerivative · entry 1

Dahlquist Karl S. · CIK 0001861996 · Chief Legal Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 87,319

F1 · price: This transaction was executed in multiple trades at prices ranging from $48.88 to $48.89 per share. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

SEC source: 0001566083-26-000006 · wk-form4_1786108718.xml · nonDerivative · entry 1

Prange Karen · CIK 0001566083 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 22,809

SEC source: 0001796057-26-000010 · wk-form4_1786108711.xml · nonDerivative · entry 1

Yuen Maggie · CIK 0001796057 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 14,015

F1 · price: This transaction was executed in multiple trades at prices ranging from $38.37 to $38.43 per share. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

SEC source: 0001230584-26-000008 · wk-form4_1785755898.xml · nonDerivative · entry 2

CARREL MICHAEL H · CIK 0001230584 · Director · President, CEO, & Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 774,434

F2 · price: No consideration was received in connection with this charitable gift.

SEC source: 0001230584-26-000008 · wk-form4_1785755898.xml · nonDerivative · entry 1

CARREL MICHAEL H · CIK 0001230584 · Director · President, CEO, & Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 778,434

F1 · price: No consideration was received in connection with this gift to the reporting person's parent.

SEC source: 0001666600-26-000004 · wk-form4_1785445064.xml · nonDerivative · entry 1

Noznesky Justin J · CIK 0001666600 · Chief Mktg & Strategy Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 100,219

F1 · price: This transaction was executed in multiple trades at prices ranging from $38.62 to $39.28 per share. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

SEC source: 0001862458-26-000011 · wk-form4_1785445076.xml · nonDerivative · entry 1

Doraiswamy Vinayak · CIK 0001862458 · Chief Scientific Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 86,511

F1 · price: This transaction was executed in multiple trades at prices ranging from $38.87 to $38.92 per share. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

SEC source: 0001205069-26-000005 · wk-form4_1785445070.xml · derivative · entry 3

WEHRWEIN SVEN · CIK 0001205069 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Non-qualified Stock Option (right to buy) · 25,000 shares

Expires 2026-11-11

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: These options were granted on November 11, 2016. These options vest and are exercisable as to 25% of the shares one year from the date of grant and the remaining 75% thereafter vests and are exercisable in equal monthly installments on the same day of the month over the following three years.

SEC source: 0001205069-26-000005 · wk-form4_1785445070.xml · nonDerivative · entry 2

WEHRWEIN SVEN · CIK 0001205069 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 40,518

F1 · price: This transaction was executed in multiple trades at prices ranging from $37.73 to $39.04 per share. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

SEC source: 0001205069-26-000005 · wk-form4_1785445070.xml · nonDerivative · entry 1

WEHRWEIN SVEN · CIK 0001205069 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 65,518

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001862458-26-000008 · wk-form4_1782997495.xml · nonDerivative · entry 1

Doraiswamy Vinayak · CIK 0001862458 · Chief Scientific Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 92,511

F1 · shares: Shares acquired pursuant to the AtriCure, Inc. 2018 Employee Stock Purchase Plan for the period ended June 30, 2026.

F2 · price: In accordance with the ESPP, these shares were purchased based on 85% of the closing price of the issuer's common stock on June 30, 2026, which is the last trading day of the applicable offering period. The closing price on June 30, 2026, was $27.98.

SEC source: 0001861996-26-000004 · wk-form4_1782997415.xml · nonDerivative · entry 1

Dahlquist Karl S. · CIK 0001861996 · Chief Legal Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 96,689

F1 · shares: Shares acquired pursuant to the AtriCure, Inc. 2018 Employee Stock Purchase Plan for the period ended June 30, 2026.

F2 · price: In accordance with the ESPP, these shares were purchased based on 85% of the closing price of the issuer's common stock on June 30, 2026, which is the last trading day of the applicable offering period. The closing price on June 30, 2026, was $27.98.

SEC source: 0001230584-26-000006 · wk-form4_1782997589.xml · nonDerivative · entry 1

CARREL MICHAEL H · CIK 0001230584 · Director · President, CEO, & Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 779,134

F1 · shares: Shares acquired pursuant to the AtriCure, Inc. 2018 Employee Stock Purchase Plan for the period ended June 30, 2026.

F2 · price: In accordance with the ESPP, these shares were purchased based on 85% of the closing price of the issuer's common stock on June 30, 2026, which is the last trading day of the applicable offering period. The closing price on June 30, 2026, was $27.98.

SEC source: 0001565823-26-000006 · wk-form4_1782997211.xml · nonDerivative · entry 1

Seith Douglas J · CIK 0001565823 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 229,867

F1 · shares: Shares acquired pursuant to the AtriCure, Inc. 2018 Employee Stock Purchase Plan for the period ended June 30, 2026.

F2 · price: In accordance with the ESPP, these shares were purchased based on 85% of the closing price of the issuer's common stock on June 30, 2026, which is the last trading day of the applicable offering period. The closing price on June 30, 2026, was $27.98.

SEC source: 0001336063-26-000004 · wk-form4_1782997077.xml · nonDerivative · entry 1

Privitera Salvatore · CIK 0001336063 · Chief Technical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 158,684

F1 · shares: Shares acquired pursuant to the AtriCure, Inc. 2018 Employee Stock Purchase Plan for the period ended June 30, 2026.

F2 · price: In accordance with the ESPP, these shares were purchased based on 85% of the closing price of the issuer's common stock on June 30, 2026, which is the last trading day of the applicable offering period. The closing price on June 30, 2026, was $27.98.

SEC source: 0001566083-26-000004 · wk-form4_1779454631.xml · nonDerivative · entry 1

Prange Karen · CIK 0001566083 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 26,373

F1 · price: This transaction was executed in multiple trades at prices ranging from $28.60 to $28.76 per share. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

SEC source: 0002006261-26-000002 · wk-form4_1779283537.xml · nonDerivative · entry 1

Nachman Shlomo · CIK 0002006261 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 24,655

F1 · shares: The Reporting Person acquired these shares pursuant to a Restricted Stock Award under the AtriCure, Inc. 2023 Stock Incentive Plan. The shares will vest upon the one-year anniversary of the grant date.

SEC source: 0001860008-26-000002 · wk-form4_1779294824.xml · nonDerivative · entry 1

Telman Deborah H · CIK 0001860008 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 28,328

F1 · shares: The Reporting Person acquired these shares pursuant to a Restricted Stock Award under the AtriCure, Inc. 2023 Stock Incentive Plan. The shares will vest upon the one-year anniversary of the grant date.

SEC source: 0001231984-26-000002 · wk-form4_1779283531.xml · nonDerivative · entry 1

JOHNSON B KRISTINE · CIK 0001231984 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 55,954

F1 · shares: The Reporting Person acquired these shares pursuant to a Restricted Stock Award under the AtriCure, Inc. 2023 Stock Incentive Plan. The shares will vest upon the one-year anniversary of the grant date.

SEC source: 0001205069-26-000003 · wk-form4_1779283518.xml · nonDerivative · entry 1

WEHRWEIN SVEN · CIK 0001205069 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 40,518

F1 · shares: The Reporting Person acquired these shares pursuant to a Restricted Stock Award under the AtriCure, Inc. 2023 Stock Incentive Plan. The shares will vest upon the one-year anniversary of the grant date.

SEC source: 0001566083-26-000002 · wk-form4_1779295456.xml · nonDerivative · entry 1

Prange Karen · CIK 0001566083 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 29,373

F1 · shares: The Reporting Person acquired these shares pursuant to a Restricted Stock Award under the AtriCure, Inc. 2023 Stock Incentive Plan. The shares will vest upon the one-year anniversary of the grant date.

SEC source: 0001796057-26-000008 · wk-form4_1779285387.xml · nonDerivative · entry 1

Yuen Maggie · CIK 0001796057 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 17,515

F1 · shares: The Reporting Person acquired these shares pursuant to a Restricted Stock Award under the AtriCure, Inc. 2023 Stock Incentive Plan. The shares will vest upon the one-year anniversary of the grant date.

SEC source: 0001653877-26-000004 · wk-form4_1779283525.xml · nonDerivative · entry 1

GROVES REGINA E · CIK 0001653877 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 39,859

F1 · shares: The Reporting Person acquired these shares pursuant to a Restricted Stock Award under the AtriCure, Inc. 2023 Stock Incentive Plan. The shares will vest upon the one-year anniversary of the grant date.

SEC source: 0001571208-26-000005 · wk-form4_1779283512.xml · nonDerivative · entry 1

WHITE ROBERT S. · CIK 0001571208 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 128,318

F1 · shares: The Reporting Person acquired these shares pursuant to a Restricted Stock Award under the AtriCure, Inc. 2023 Stock Incentive Plan. The shares will vest upon the one-year anniversary of the grant date.

SEC source: 0001862458-26-000006 · wk-form4_1779134506.xml · nonDerivative · entry 1

Doraiswamy Vinayak · CIK 0001862458 · Chief Scientific Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 91,875

SEC source: 0001862458-26-000004 · wk-form4_1773663272.xml · nonDerivative · entry 1

Doraiswamy Vinayak · CIK 0001862458 · Chief Scientific Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 96,875

F1 · price: This transaction was executed in multiple trades at prices ranging from $29.79 to $29.92 per share. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

SEC source: 0001571208-26-000002 · wk-form4_1773319961.xml · derivative · entry 2

WHITE ROBERT S. · CIK 0001571208 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Non-qualified Stock Option (right to buy) · 10,000 shares

Expires 2026-05-25

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_date: These options were granted on May 25, 2016. These options vest and are exercisable as to 25% of the shares one year from the date of grant and the remaining 75% thereafter vests and are exercisable in equal monthly installments on the same day of the month over the following three years.

SEC source: 0001571208-26-000002 · wk-form4_1773319961.xml · nonDerivative · entry 1

WHITE ROBERT S. · CIK 0001571208 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 122,174

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001230584-26-000004 · wk-form4_1773059554.xml · nonDerivative · entry 2

CARREL MICHAEL H · CIK 0001230584 · Director · President, CEO, & Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 778,498

F2 · price: No consideration was received in conjunction with this gift to the reporting person's sibling.

SEC source: 0001230584-26-000004 · wk-form4_1773059554.xml · nonDerivative · entry 1

CARREL MICHAEL H · CIK 0001230584 · Director · President, CEO, & Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 779,498

F1 · price: No consideration was received in connection with this gift to the reporting person's children.

SEC source: 0001862458-26-000002 · wk-form4_1772574768.xml · nonDerivative · entry 3

Doraiswamy Vinayak · CIK 0001862458 · Chief Scientific Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 101,875

F3 · shares: The Reporting Person has elected to transfer these shares to the Company to satisfy the tax withholding obligation incurred upon the vesting and release of shares previously acquired pursuant to a Restricted Stock Award or Performance Share Award.

SEC source: 0001862458-26-000002 · wk-form4_1772574768.xml · nonDerivative · entry 2

Doraiswamy Vinayak · CIK 0001862458 · Chief Scientific Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 117,460

F2 · price: The Reporting Person acquired these shares pursuant to the vesting and release of a Performance Share Award under the AtriCure, Inc. 2023 Stock Incentive Plan. The award had Company performance goals and a service period requirement which were met.

SEC source: 0001862458-26-000002 · wk-form4_1772574768.xml · nonDerivative · entry 1

Doraiswamy Vinayak · CIK 0001862458 · Chief Scientific Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 102,262

F1 · price: The Reporting Person acquired these shares pursuant to a Restricted Stock Award under the AtriCure, Inc. 2023 Stock Incentive Plan. One third of the shares will vest annually upon the respective one, two, and three year anniversaries of the date of grant.

SEC source: 0001861996-26-000002 · wk-form4_1772574742.xml · nonDerivative · entry 3

Dahlquist Karl S. · CIK 0001861996 · Chief Legal Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 96,053

F3 · shares: The Reporting Person has elected to transfer these shares to the Company to satisfy the tax withholding obligation incurred upon the vesting and release of shares previously acquired pursuant to a Restricted Stock Award or Performance Share Award.

SEC source: 0001861996-26-000002 · wk-form4_1772574742.xml · nonDerivative · entry 2

Dahlquist Karl S. · CIK 0001861996 · Chief Legal Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 111,740

F2 · price: The Reporting Person acquired these shares pursuant to the vesting and release of a Performance Share Award under the AtriCure, Inc. 2023 Stock Incentive Plan. The award had Company performance goals and a service period requirement which were met.

SEC source: 0001861996-26-000002 · wk-form4_1772574742.xml · nonDerivative · entry 1

Dahlquist Karl S. · CIK 0001861996 · Chief Legal Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 96,542

F1 · price: The Reporting Person acquired these shares pursuant to a Restricted Stock Award under the AtriCure, Inc. 2023 Stock Incentive Plan. One third of the shares will vest annually upon the respective one, two, and three year anniversaries of the date of grant.

SEC source: 0001819885-26-000002 · wk-form4_1772574759.xml · nonDerivative · entry 3

Wirick Angela L · CIK 0001819885 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 204,893

F3 · shares: The Reporting Person has elected to transfer these shares to the Company to satisfy the tax withholding obligation incurred upon the vesting and release of shares previously acquired pursuant to a Restricted Stock Award or Performance Share Award.

SEC source: 0001819885-26-000002 · wk-form4_1772574759.xml · nonDerivative · entry 2

Wirick Angela L · CIK 0001819885 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 227,858

F2 · price: The Reporting Person acquired these shares pursuant to the vesting and release of a Performance Share Award under the AtriCure, Inc. 2023 Stock Incentive Plan. The award had Company performance goals and a service period requirement which were met.

SEC source: 0001819885-26-000002 · wk-form4_1772574759.xml · nonDerivative · entry 1

Wirick Angela L · CIK 0001819885 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 204,757

F1 · price: The Reporting Person acquired these shares pursuant to a Restricted Stock Award under the AtriCure, Inc. 2023 Stock Incentive Plan. One third of the shares will vest annually upon the respective one, two, and three year anniversaries of the date of grant.

SEC source: 0001666600-26-000002 · wk-form4_1772574787.xml · nonDerivative · entry 3

Noznesky Justin J · CIK 0001666600 · Chief Mktg & Strategy Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 106,401

F3 · shares: The Reporting Person has elected to transfer these shares to the Company to satisfy the tax withholding obligation incurred upon the vesting and release of shares previously acquired pursuant to a Restricted Stock Award or Performance Share Award.

SEC source: 0001666600-26-000002 · wk-form4_1772574787.xml · nonDerivative · entry 2

Noznesky Justin J · CIK 0001666600 · Chief Mktg & Strategy Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 121,987

F2 · price: The Reporting Person acquired these shares pursuant to the vesting and release of a Performance Share Award under the AtriCure, Inc. 2023 Stock Incentive Plan. The award had Company performance goals and a service period requirement which were met.

SEC source: 0001666600-26-000002 · wk-form4_1772574787.xml · nonDerivative · entry 1

Noznesky Justin J · CIK 0001666600 · Chief Mktg & Strategy Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 106,789

F1 · price: The Reporting Person acquired these shares pursuant to a Restricted Stock Award under the AtriCure, Inc. 2023 Stock Incentive Plan. One third of the shares will vest annually upon the respective one, two, and three year anniversaries of the date of grant.

SEC source: 0001230584-26-000002 · wk-form4_1772574793.xml · nonDerivative · entry 3

CARREL MICHAEL H · CIK 0001230584 · Director · President, CEO, & Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 784,498

F3 · shares: The Reporting Person has elected to transfer these shares to the Company to satisfy the tax withholding obligation incurred upon the vesting and release of shares previously acquired pursuant to a Restricted Stock Award or Performance Share Award.

SEC source: 0001230584-26-000002 · wk-form4_1772574793.xml · nonDerivative · entry 2

CARREL MICHAEL H · CIK 0001230584 · Director · President, CEO, & Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 857,275

F2 · price: The Reporting Person acquired these shares pursuant to the vesting and release of a Performance Share Award under the AtriCure, Inc. 2023 Stock Incentive Plan. The award had Company performance goals and a service period requirement which were met.

SEC source: 0001230584-26-000002 · wk-form4_1772574793.xml · nonDerivative · entry 1

CARREL MICHAEL H · CIK 0001230584 · Director · President, CEO, & Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 755,995

F1 · price: The Reporting Person acquired these shares pursuant to a Restricted Stock Award under the AtriCure, Inc. 2023 Stock Incentive Plan. One third of the shares will vest annually upon the respective one, two, and three year anniversaries of the date of grant.

SEC source: 0001336063-26-000002 · wk-form4_1772574779.xml · nonDerivative · entry 3

Privitera Salvatore · CIK 0001336063 · Chief Technical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 158,048

F3 · shares: The Reporting Person has elected to transfer these shares to the Company to satisfy the tax withholding obligation incurred upon the vesting and release of shares previously acquired pursuant to a Restricted Stock Award or Performance Share Award.